Blood Cancers Today
@Blood_Cancers
Followers
1,115
Following
259
Media
1,475
Statuses
2,850
Translating Hematologic Oncology Discoveries into Practice.
Joined September 2021
Don't wanna be here?
Send us removal request.
Explore trending content on Musk Viewer
#RafahOnFıre
• 1402506 Tweets
Armageddon
• 578826 Tweets
都知事選
• 180909 Tweets
giselle
• 100017 Tweets
İsrail
• 89128 Tweets
#CDTVライブライブ
• 75753 Tweets
#THEDANCEDAY
• 65306 Tweets
Fermín
• 52080 Tweets
아마겟돈
• 45348 Tweets
ドラクエ12
• 43458 Tweets
SAKAMOTO DAYS
• 40909 Tweets
الجيش المصري
• 33203 Tweets
Maresca
• 24705 Tweets
علي جنود
• 18101 Tweets
Jarabe
• 11342 Tweets
Pablo Iglesias
• 10228 Tweets
Cubarsí
• 10184 Tweets
Neuro-oncologist
@michelle_monje
, along with
@VirusesImmunity
and
@PutrinoLab
, discovered that chemotherapy and COVID-19 infection cause neuro-inflammation in similar ways
1
22
55
🌟ICYMI: In this video,
@DrStass
, who researches T-cell ALL at
@pmcancercentre
, speaks about what it means to be named an
@AACR
NextGen Star and the importance of the opportunity for early career investigators🌟
📺:
@PMResearch_UHN
@UofT
@UHN
#AACR23
3
2
42
“Graphical abstract” on the current state of AML classification by
@sanamloghavi
at
#SOHO23
@SocietyofHemOnc
0
9
34
🔊OUT NOW: This all-new episode of The HemOnc Pulse features
@BldCancerDoc
of
@SarahCannonDocs
and host
@chadinabhan
discussing CAR-T logistics and access, as well as the role of CAR-T amidst the availability of bispecific antibodies.
@SocietyofHemOnc
1
10
33
June is Acute Myeloid Leukemia Awareness Month.
In this new video,
@Dr_AmerZeidan
of
@Yale
speaks about what AML Awareness Month means to him as a clinician and a researcher.
📺:
#leusm
1
8
33
Today marks AML World Awareness Day.
In this new video,
@sanamloghavi
of
@MDAndersonNews
discusses the importance of AML World Awareness Day, and how clinicians & researchers can educate others about
#AML
.
📺Watch:
#AMLWorldAwarenessDay
#KnowAML
#leusm
1
12
32
In this feature,
@NoopurRajeMD
of
@MGHCancerCenter
and
@harvardmed
reflects on the mentors who shaped her career, seeing myeloma treatments go from the bench to the bedside, and the importance of personal priorities during a career in academic medicine.
1
7
32
🌟ICYMI: In this video,
@CLJonesLab
of
@pmcancercentre
speaks about her research on leukemia, what it means to be named an
@AACR
NextGen Star, and the importance of mentorship.🌟
📺:
@PMResearch_UHN
@UHN
@UofT
0
5
30
ICYMI: June is Acute Myeloid Leukemia Awareness Month.
In this video,
@Dr_AmerZeidan
of
@Yale
speaks about what AML Awareness Month means to him as a clinician and a researcher.
📺:
#leusm
1
5
30
Do you think CAR-T will replace AHSCT in multiple myeloma?
@DoctorAKrishnan
of
@cityofhopeoc
and
@szusmani
of
@MSKCancerCenter
shared their thoughts on the matter in this Point | Counterpoint feature.
@SocietyofHemOnc
2
9
29
🔊OUT NOW: This all-new episode of The HemOnc Pulse features host
@chadinabhan
speaking with
@Dr_AmerZeidan
of
@yale
about the impact of AML classification updates, how patient characteristics inform his approach to treating AML, and more.
@SocietyofHemOnc
0
4
29
S. Vincent Rajkumar (
@VincentRK
) of the
@MayoClinic
recently assumed the role of Chairperson of the
@IMFmyeloma
Board of Directors!
Read more:
3
4
28
ICYMI:
@NoopurRajeMD
of
@MGHCancerCenter
/
@harvardmed
reflects on the mentors who shaped her career, seeing myeloma treatments go from the bench to the bedside, and the importance of personal priorities during a career in academic medicine.
0
6
26
Mahalo nui loa to
@MazieTsangMD
for stopping by Blood Cancers Today to share about her medical career and how her experience
@uhmed
taught her "to honor patients’ values, perspectives, and cultures.”
@SocietyofHemOnc
1
4
27
The
#ASCO23
session on hematologic malignancies - leukemia, myelodysplastic syndromes, and allotransplant has kicked off with a presentation by
@drclaireroddie
of
@ucl
on top line results of the FELIX study, which evaluated obecabtagene autoleucel in relapsed/refractory B-ALL.
0
6
24
ICYMI:
@NoopurRajeMD
of
@MGHCancerCenter
/
@harvardmed
reflects on the mentors who shaped her career, seeing myeloma treatments go from the bench to the bedside, and the importance of personal priorities during a career in academic medicine.
📚:
1
5
24
ICYMI: What's the role of transplant in newly diagnosed systemic light chain amyloidosis?
@SLentzsch
of
@columbiacancer
and
@SandyWong02111
of
@UCSF
shared their thoughts in this Point | Counterpoint debate.
0
8
23
DDX41 defies current risk stratification for MDS.
R525H mutation results in leukemic transformation.
Transplant important for high risk DDX41 patients!
Congrats
@CarmeloGurnari
@NicoGagelmann
#mdssm
#ASH23
0
9
23
Don't miss the new episode of The HemOnc Pulse on July 27 featuring
@NitinJainMD
discussing venetoclax and combo therapies in
#CLL
with host
@chadinabhan
.
Subscribe to all of the latest news in heme onc at:
@MDAndersonNews
@SocietyofHemOnc
1
4
20
Ponatinib was more effective than imatinib when given with reduced-intensity chemotherapy in patients with newly diagnosed Ph+ ALL, according to results from the phase III PhALLCON trial by Elias Jabbour, MD, of
@MDAndersonNews
, and colleagues.
2
7
19
Venetoclax plus cladribine, idarubicin, cytarabine showed promise in patients with newly diagnosed AML or high-risk MDS, according to a recent study by Patrick Reville, MD, MPH,
@patrickreville
of
@MDAndersonNews
, and colleagues.
@SocietyofHemOnc
0
6
19
In the first video of a new myeloma roundtable series,
@szusmani
of
@MSKCancerCenter
;
@YiLinMDPhD
of
@MayoClinic
; Shambavi Richard, MD of
@TischCancer
; and
@MeeraMohanMD
of
@MedicalCollege
, weigh in on triplets vs quadruplets in multiple myeloma.
📺
0
4
18
Let's start the Orals
#ASH23
in
#myeloma
with real world analysis on teclistamab by
@DimaDanai
@ClevelandClinic
#mmsm
-overall response similar to trial
-complete response lower than trial
-extramedullary disease and low performance status is bad
Congrats!
@NicoGagelmann
1
6
19
Keep an eye out for our next roundtable, which will feature
@YiLinMDPhD
;
@szusmani
; Shambavi Richard, MD; and
@MeeraMohanMD
!
#ASCO23
0
3
19
Happening now at
#ASCO23
:
@Dr_AmerZeidan
of
@Yale
is presenting results from the phase III IMerge study, which evaluated imetelstat in certain patients with LR-MDS.
0
2
18
🔊OUT NOW: This all-new episode of The HemOnc Pulse features
@mshadman
of
@fredhutch
discussing the most notable data on CLL from the summer conference season and what he sees on the horizon with host
@chadinabhan
.
Listen:
@SocietyofHemOnc
0
5
18
A triplet of decitabine, venetoclax, and ponatinib was well tolerated in patients with CML in myeloid blast phase or Ph+ AML, according to an ongoing phase II study presented by
@jayastuMD
of
@MDAndersonNews
during
#ASH22
.
1
4
17
At
#ASH23
,
@NicoGagelmann
stopped by Blood Cancers Today to talk about CAR-T versus
#HSCT
for relapsed
#multiplemyeloma
.
📺 Watch here!
0
2
17
In this new video,
@drsangeetmd
of
@SylvesterCancer
/
@UMiamiHealth
weighs in on the phase III COMMANDS trial data presented by
@garciamanero
of
@MDAndersonNews
during
#ASCO23
.
📺:
0
3
17
In our latest Get to Know feature, John DiPersio, MD, PhD, of
@DiPersioLab
/
@wustlmed
/
@sitemancenter
, discusses the key events that shaped his career, his lab’s most transformative research, the future of transplant, and more.
📚:
0
3
16
Blood Cancers Today is the official news publication of
@SocietyofHemOnc
. Under the leadership of Editor-in-Chief
@SagarLonialMD
, BCT covers the latest news and research in hematologic malignancies, offering insight from innovators and experts in the hematology/oncology field.
0
4
16
Thank you to
@kanagalshamanna
of
@MDAndersonNews
for taking the time to discuss the optical genome mapping platform and its clinical implications for MDS and AML.
0
6
16
Looking forward to catching up on podcasts this evening?
Check out The HemOnc Pulse, which is hosted by
@chadinabhan
and has featured guests including
@GregNowakowski
,
@doctorpemm
,
@BldCancerDoc
,
@Dr_AmerZeidan
,
@ASkarbnik
,
@DrLizBrem
, &
@sanamloghavi
.
🔊
1
5
16
Second-year internal medicine resident Mustafa Wasifuddin, MD (
@teeshake
), joined
@chadinabhan
to discuss his research on racial disparities in
#DLBCL
at
#ASH23
.
Watch the full conversation ➡️
0
3
16
Congratulations to our Blood Cancers Today Editorial Board member, Dr. Elias Jabbour, of
@MDAndersonNews
, for receiving the King Hussein Lifetime Achievement Award for Cancer Research at this year's King Hussein Cancer Research Conference.
@KHCFKHCC
@SocietyofHemOnc
Many congratulations to dr Elias Jabbour
@MDAndersonNews
for winning the Life Achievement Award for Cancer Research in
@KHCFKHCC
Annual Cancer Research Awards meeting in Jordan 🇯🇴
@doctorpemm
8
9
141
0
1
16
📢COMING SOON:
@RahulBanerjeeMD
of
@UWMedicine
&
@fredhutch
will be taking over
@blood_cancers
during the
@Myeloma_Society
's 2023 Annual Meeting, which kicks off Wednesday in Athens!
📰Stay tuned for all the latest news and key developments from
#IMS2023
!
#mmsm
#IMS23
1
4
15
Catching up on all the key hem/onc news from the 2023
@ASCO
Annual Meeting?
In this video,
@drsangeetmd
of
@SylvesterCancer
/
@UMiamiHealth
weighs in on data from the phase III COMMANDS trial presented by
@garciamanero
of
@MDAndersonNews
at
#ASCO2023
.
📺
0
3
16
Lenalidomide-associated acute lymphoblastic leukemia was seen in patients with multiple myeloma, but discontinuation alone led to regression of clonal populations.
Read more about this study, led by
@MarkGeyerMD
, of
@MSKCancerCenter
.
📝
0
7
16
In this video interview,
@SwethaKamMD
of
@cityofhope
discusses her
#ASCO23
presentation on real-world outcomes of brexucabtagene autoleucel in relapsed or refractory MCL with
@chadinabhan
.
📺:
1
3
15
More than one-third of patients with MDS and their caregivers had “concerning levels of depression and/or anxiety,” according to research by Katherine DiNardo, MD, of
@DukeMedSchool
.
0
6
15
COMING SOON:
@sanamloghavi
of
@MDAndersonNews
takes over
@Blood_Cancers
next week for a special livestream with
@chadinabhan
at
#SOHO2023
!
Tune in at 3 PM CT Thursday for all the latest news from the Eleventh
@SocietyofHemOnc
Annual Meeting!
#SOHO23
,
#leusm
,
#lymsm
,
#mmsm
1
5
15
🥳🎉 Out now: the first podcast episode from
#HOPLive24
!
🎙️ Panelists
@Daver_Leukemia
,
@sanamloghavi
,
@Ramikomrokji
, and
@MikkaelSekeres
join
@chadinabhan
to discuss unanswered questions in
#AML
.
🎧 Listen here!
1
7
16
Thanks to
@garciamanero
of
@MDAndersonNews
for stopping by to discuss results from the phase III COMMANDS study with us during
#ASCO23
!
Look for the full video interview with Dr. Garcia-Manero here soon!
1
0
15
Is it time for a unified approach to MDS?
In this new feature,
@JoeKhouryMD
; Daniel Arber, MD;
@DavidSteensma
;
@UwePlatzbecker
;
@drsomedeb
;
@Ramikomrokji
; and Robert Hasserjian, MD, weigh in on the WHO and ICC systems and how to move forward.
📚:
0
6
15
🙌 ICYMI: The
@CRTFund
Lifetime Achievement Award recognized
@JohnPLeonardMD
, of
@WeillCornell
and
@NYPhospital
, for his research in lymphoma.
Read more:
0
0
15
Out now! 🥳 The
#MDS
panel from
#HOPLive24
discusses:
☑️ How to classify and define MDS and CHIP
☑️ How to treat low- and high-risk MDS
☑️ How to approach transplant
Check it out!
@Ramikomrokji
@Dr_AmerZeidan
@drsangeetmd
@sanamloghavi
@chadinabhan
0
6
15
🔊Looking for a great listen this weekend?
Don't miss this episode of The HemOnc Pulse, which features
@BldCancerDoc
of
@SarahCannonDocs
discussing CAR-T logistics, access, and other key considerations with host
@chadinabhan
.
@SocietyofHemOnc
0
3
15
Time for another
#ASH23
video insight!
In this interview,
@CarlynRTanMD
, of
@MSKCancerCenter
, discussed her retrospective study on teclistamab treatment for multiple myeloma.
Watch here:
2
6
14
In this new video,
@Dr_AmerZeidan
of
@Yale
discusses the phase III IMerge data he presented at
#ASCO23
, the study's implications, and what he sees as the next steps.
📺:
0
6
14
A novel early relapse scoring system for patients with MM undergoing AHSCT identified five discrete prognostic groups, according to a study from the chronic malignancies working party of
@TheEBMT
published by
@mbeksac56
of
@AnkaraUni
and colleagues.
📚:
0
3
14
On the heels of
#IMS23
, we're happy to present
@szusmani
&
@TomBmt133
with our prize for the friendliest boxing hype-up photo of all time* 🥊🥊
* Actually a fierce face-off in
#MMsm
that was our most read story of the year, even before
#IMS23
. Read below!
1
4
14
In this video interview,
@Rachel_Thijssen
of
@CancerCenterAms
speaks about the session she chaired during the
@young_eha
Research Meeting at
#EHA2023
and the importance of bringing young researchers together at the 2023
@EHA_Hematology
Congress!
📺:
0
2
14
🔊Looking for a great listen this weekend?
Don't miss the latest episode of The HemOnc Pulse, which features
@BldCancerDoc
of
@SarahCannonDocs
discussing CAR-T logistics, access, and other key considerations with host
@chadinabhan
.
@SocietyofHemOnc
0
2
13
@sanamloghavi
also discussed
#MRD
in
#AML
:
"Not all MRD is created equally," she said. "Not all the assays are as sensitive. So, you really have to know what you're using and how to interpret the data in the context of the greater picture."
0
3
14
🙌
@sanamloghavi
, of
@MDAndersonNews
, reflects on "The HemOnc Pulse" Live and how it sheds a spotlight on hematopathology!
Hear what she has to say, and stay tuned for the live meeting on May 3-4 in Chicago!
📺
#HOPLive24
@chadinabhan
1
5
14
In our latest "Get to Know" feature,
@Dr_AmerZeidan
of
@Yale
/
@YaleCancer
reflects on a patient who shaped his career path, what he sees as the most pressing questions in the field, and the importance of hope.
📚:
1
4
14
ICYMI: Will CAR-T will replace AHSCT in multiple myeloma?
@DoctorAKrishnan
of
@cityofhopeoc
and
@szusmani
of
@MSKCancerCenter
share their thoughts on the topic in this Point | Counterpoint feature.
Read more:
0
4
14
In this new video from the myeloma roundtable series,
@szusmani
of
@MSKCancerCenter
;
@YiLinMDPhD
of
@MayoClinic
; Shambavi Richard, MD of
@TischCancer
; and
@MeeraMohanMD
of
@MedicalCollege
, discuss maintenance therapy strategies for multiple myeloma.
📺:
0
6
12
We had SO much fun in Chicago at
#HOPLive24
this weekend! Check out our coverage and stay tuned for:
⭐ Podcast episodes from each session
⭐ Roundtable discussions
⭐ One-on-one interviews
@chadinabhan
@Dr_AmerZeidan
@MdSwoboda
@doctorpemm
@mpdrc
2
4
13
It's Day 1 of
#HOPLive24
! 😍
Join the conversation as
@mrbishop_UC_BMT
,
@ASkarbnik
,
@Daver_Leukemia
,
@MikkaelSekeres
,
@jmikhaelmd
, and more join
@chadinabhan
for panels, interviews, and more exciting stuff!
➡️
0
7
13
0
3
13
Looking for a great read over the weekend?
In this feature,
@LNastoupilMD
of
@MDAndersonNews
reflects on her upbringing in New Mexico, her research on disparities in lymphoma, the importance of representation in practice-changing trials, and more.
0
4
13
MPN community saw a potential paradigm shift in treating patients with
#myelofibrosis
Combination of pelabresib+ruxolitinib resulted in high and deep spleen responses and astonishing tolerability
#mpnsm
@NicoGagelmann
#ASH23
0
2
12
Another episode of The HemOnc Pulse just dropped! 🤩
This time,
@ASkarbnik
, of
@NovantHealth
, joined
@chadinabhan
to discuss practice-changing research in
#DLBCL
presented at
#ASH23
.
🎧 Listen here:
0
5
13
🌟 The lights are shining on the stars of the
#MPN
roundtable!
More to come from
#HOPLive24
😊
@doctorpemm
@mpdrc
@sanamloghavi
@myeloidmalig
0
1
13
What's the latest in MDS and AML?
@Ramikomrokji
of
@MoffittNews
and
@Daver_Leukemia
of
@MDAndersonNews
stopped by The HemOnc Pulse at
#SOHO23
to share their thoughts with
@chadinabhan
.
Don't miss this great discussion!
📺
0
1
13
In the latest video from the myeloma roundtable series,
@szusmani
of
@MSKCancerCenter
;
@YiLinMDPhD
of
@MayoClinic
; Shambavi Richard, MD of
@TischCancer
; and
@MeeraMohanMD
of
@MedicalCollege
, discuss FDA-approved BCMA-directed CAR-T options for MM.
📺:
0
3
13
As Acute Myeloid Leukemia Awareness Month wraps up, don't miss this video featuring
@Dr_AmerZeidan
of
@Yale
sharing what AML Awareness Month means to him as a clinician and a researcher.
📺:
#leusm
0
1
13
Thanks to
@AjaiChari
of
@UCSF
for stopping by to discuss the recent FDA accelerated approval of talquetamab for relapsed or refractory multiple myeloma.
Stay tuned for the full video interview and sign up to get the latest news in your inbox:
#mmsm
0
1
13
Recently,
@TaylorJ_MD
, of
@SylvesterCancer
, joined BCT to discuss a study on overcoming BTK-Resistant mutations in
#CLL
.
Dr. Taylor and his team developed the BTK degrader NX-2127, which achieved clinical responses in 79% of patients.
📰 Read more!
0
2
13
What are the "ABCs" of multiple myeloma treatment?
@Rfonsi1
jumped on The HemOnc Pulse to chat with
@chadinabhan
about the future of MM treatment, the ongoing debate between CAR-T therapies and bispecifics, and the latest news on bispecifics.
🎧
0
7
13
ICYMI: Should CAR-T or a bispecific antibody be used to treat relapsed/refractory multiple myeloma?
@TomBmt133
of
@UCSFCancer
and
@szusmani
of
@MSKCancerCenter
debate the topic in this Point | Counterpoint feature.
0
3
12
🔊Coming Thursday, 3/23: An all-new episode of The HemOnc Pulse features host
@chadinabhan
speaking with
@SwethaKMD
of
@cityofhope
and Nikhil Thiruvengadam, MD, of
@UCSF
about modeling the cost effectiveness of pola-R-CHP in relation to other DLBCL therapies.
@SocietyofHemOnc
0
5
12
🎬 Live in Chicago, it's "The HemOnc Pulse!"
🎉 Get ready for "The HemOnc Pulse" Live on May 3-4 with
@chadinabhan
as he curates all the latest news in hematology oncology with leaders in the field like
@Rfonsi1
,
@sanamloghavi
, and more!
➡️ Learn more:
0
5
13
Jennifer Brown, MD, PhD, Discusses Genomic Evolution of Pirtobrutinib Resistance in Frankfurt at the 2023 EHA Congress
@SocietyofHemOnc
@EHA_Hematology
#EHA2023
1
3
12
We have another special
#ASH23
episode of The HemOnc Pulse!
This time,
@drsangeetmd
spoke with
@chadinabhan
about the latest MDS news from ASH—including the investigational drug KER-050, and whether she believes MDS is a distinct disease.
🎧Listen here!
2
4
11
How does CAR-T impact the standard of care in myeloma?
In the second segment of this all-new myeloma roundtable series, hear from
@SagarLonialMD
of
@WinshipAtEmory
;
@NoopurRajeMD
of
@harvardmed
,
@MGHCancerCenter
; and
@DrKrinaPatel
of
@MDAndersonNews
.
📺
0
4
12
Looking for a great listen this weekend?
Check out The HemOnc Pulse, which is hosted by
@chadinabhan
and has featured guests including
@tinabhatnagar01
,
@NitinJainMD
,
@SwethaKamMD
,
@BldCancerDoc
,
@ASkarbnik
,
@Dr_AmerZeidan
,
@graham74GC
&
@SagarLonialMD
.
0
3
12
Venetoclax plus azacitidine maintenance therapy after allogeneic HSCT showed “encouraging activity” in patients with high-risk MDS or AML, according to a study by Jacqueline Garcia, MD, of
@danafarber
, and colleagues.
0
2
12
Good morning beautiful hematologists in wonderful San Diego!
Stay tuned and excited for today's
#ASH23
reports:
"Today is gonna be the day that I'm gonna throw myeloma, MDS and CAR-T at you."
@NicoGagelmann
0
3
12
In this new video, BCT Editor-in-Chief
@SagarLonialMD
of
@WinshipAtEmory
discusses the symposium he took part in during
#EHA23
and key highlights in multiple myeloma research presented during the 2023
@EHA_Hematology
Congress and the 2023
@ASCO
Meeting.
📺
0
1
12
"Rare diseases are not rare for the patients or their families that are affected by them."
@MrinalPatnaik
recognizes
#rarediseaseday
@MayoClinic
#CMML
via
@YouTube
0
4
11
Splenic irradiation before HSCT is associated with reduced spleen size and lower incidence of relapse in patients with
#myelofibrosis
.
Read more about the study, led by
@NicoGagelmann
, of
@UKEHamburg
, and published in
@AjHematology
.
📰
1
3
12
@MDAndersonNews
@TheLancetHaem
🙌 If you've been keeping up with our previous Top 5 countdowns, you're probably not surprised that this popular "HemOnc Pulse" episode with
@AaronGoodman33
&
@chadinabhan
takes the
#4
spot!
🎧 Listen to the full podcast to learn about Castleman Disease:
1
2
12
Treatment benefit from the FLT3 inhibitor quizartinib was predicted by a “FLT3-like” gene expression signature identified in patients with
#AML
both with and without FLT3 mutations, according to a study led by
@MosqueraOrgeira
of
@UniversidadeUSC
.
📖
0
2
12
While much progress has been made to improve MCL outcomes, there are still many unmet needs. We spoke with Jia Ruan, MD, PhD, of
@WeillCornell
,
@jonathonbcohen
,
@michaelwangmd
,
@LymphClinician
, and
@JainP_MCL
, to get their insights.
@SocietyofHemOnc
0
3
12
Is there a link between the microbiome and CAR-T outcomes?
Don't miss this video featuring
@MarcoRuella
of
@RuellaLab
at
@PennMedicine
discussing his research on the topic during the 2023
@EHA_Hematology
Congress.
📺:
0
4
12
ICYMI:
@NoopurRajeMD
of
@MGHCancerCenter
/
@harvardmed
reflects on the mentors who shaped her career, seeing myeloma treatments go from the bench to the bedside, and the importance of personal priorities during a career in academic medicine.
📚:
0
1
12
Data presented by
@ArnoYlitalo
of
@UniTurku
and colleagues at an
@AACR
conference "validate the therapeutic potential" of bexmarilimab, an immunotherapy under evaluation in combination with venetoclax and/or azacitidine in the phase I/II BEXMAB trial.
0
3
11
Our very own Blood Cancers Today Associate Editor Dr. Elias Jabbour vlogs on the latest leukemia news and his time in Frankfurt at the 2023 EHA Congress.
@MDAndersonNews
@SocietyofHemOnc
@SagarLonialMD
@EHA_Hematology
0
1
11
🔊OUT NOW: This all-new episode of The HemOnc Pulse features host
@chadinabhan
speaking with
@SwethaKMD
of
@cityofhope
and Nikhil Thiruvengadam, MD, about the cost effectiveness of pola-R-CHP in relation to other therapies for DLBCL.
@SocietyofHemOnc
2
4
11
A meeting of the minds!
Thanks to
@Ramikomrokji
of
@MoffittNews
and
@Daver_Leukemia
of
@MDandersonNews
for stopping by our booth to chat with
@chadinabhan
during the
#SOHO2023
meeting!
#SOHO23
#hemonc
0
1
11
Looking forward to catching up on podcasts this weekend? Check out The HemOnc Pulse, which is hosted by
@chadinabhan
and has featured guests including
@DrLizBrem
,
@sanamloghavi
,
@mpdrc
,
@DrHKantarjian
,
@SwethaKMD
, and
@graham74GC
.
0
6
11
Thanks to
@NitinJainMD
of
@MDAndersonNews
for stopping by to chat about unanswered questions in CLL with
@chadinabhan
at
#SOHO2023
!
Stay tuned for the full interview!
#SOHO23
#hemonc
0
1
11
Out now! 🎉 In this all-new episode of The HemOnc Pulse,
@GCC_Cortes
of
@GACancerCenter
chats with
@chadinabhan
about the “boom” in treatments for CML and where he sees a need for balance.
Listen now 🎧:
0
2
11
Benjamin Rolles (
@DrRolles
), of
@BrighamResearch
at
@HarvardMed
, stopped to chat with Blood Cancers Today at
#ASH23
!
Dr. Rolles discussed his abstract on TP53 mutations in patients with MPNs who were treated at
@DanaFarber
.
Check it out ➡️
0
5
10
Looking for a great listen during
#ASCO23
?
Check out The HemOnc Pulse, which is hosted by
@chadinabhan
& has featured guests including
@SagarLonialMD
,
@Dr_AmerZeidan
,
@SwethaKMD
,
@DrLizBrem
,
@sanamloghavi
,
@mpdrc
,
@DrHKantarjian
&
@graham74GC
.
0
6
10
🔊OUT NOW: In this new episode of The HemOnc Pulse,
@graham74GC
of
@OxfordCancer
discusses upfront checkpoint inhibitors in Hodgkin lymphoma, the Holistic Consortium, and more with host
@chadinabhan
.
@SocietyofHemOnc
@UniofOxford
0
4
11